738 related articles for article (PubMed ID: 19219839)
1. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
2. Methods for samples preparation in proteomic research.
Bodzon-Kulakowska A; Bierczynska-Krzysik A; Dylag T; Drabik A; Suder P; Noga M; Jarzebinska J; Silberring J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):1-31. PubMed ID: 17113834
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry: uncovering the cancer proteome for diagnostics.
van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by the filter-aided sample preparation method.
Wiśniewski JR; Zielinska DF; Mann M
Anal Biochem; 2011 Mar; 410(2):307-9. PubMed ID: 21144814
[TBL] [Abstract][Full Text] [Related]
6. Practical points in urinary proteomics.
Thongboonkerd V
J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
[TBL] [Abstract][Full Text] [Related]
7. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
deVera IE; Katz JE; Agus DB
Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
[TBL] [Abstract][Full Text] [Related]
8. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
[TBL] [Abstract][Full Text] [Related]
9. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis.
De Bock M; de Seny D; Meuwis MA; Servais AC; Minh TQ; Closset J; Chapelle JP; Louis E; Malaise M; Merville MP; Fillet M
Talanta; 2010 Jun; 82(1):245-54. PubMed ID: 20685463
[TBL] [Abstract][Full Text] [Related]
11. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
13. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
[TBL] [Abstract][Full Text] [Related]
14. Intact-protein based sample preparation strategies for proteome analysis in combination with mass spectrometry.
Wang H; Hanash S
Mass Spectrom Rev; 2005; 24(3):413-26. PubMed ID: 15389852
[TBL] [Abstract][Full Text] [Related]
15. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in mass spectrometry-based peptidome analysis.
Hu L; Ye M; Zou H
Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
[TBL] [Abstract][Full Text] [Related]
17. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
Fliser D; Wittke S; Mischak H
Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
19. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
20. Sample handling for mass spectrometric proteomic investigations of human sera.
West-Nielsen M; Høgdall EV; Marchiori E; Høgdall CK; Schou C; Heegaard NH
Anal Chem; 2005 Aug; 77(16):5114-23. PubMed ID: 16097747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
